Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Inventory (2021 - 2025)

Historic Inventory for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $16.4 million.

  • Biote's Inventory rose 151.85% to $16.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.4 million, marking a year-over-year increase of 151.85%. This contributed to the annual value of $14.8 million for FY2024, which is 1422.55% down from last year.
  • Latest data reveals that Biote reported Inventory of $16.4 million as of Q3 2025, which was up 151.85% from $12.1 million recorded in Q2 2025.
  • Biote's 5-year Inventory high stood at $19.2 million for Q2 2024, and its period low was $7.4 million during Q2 2023.
  • In the last 5 years, Biote's Inventory had a median value of $12.1 million in 2025 and averaged $13.2 million.
  • Per our database at Business Quant, Biote's Inventory skyrocketed by 15976.2% in 2024 and then crashed by 3685.2% in 2025.
  • Quarter analysis of 5 years shows Biote's Inventory stood at $9.6 million in 2021, then increased by 16.31% to $11.2 million in 2022, then surged by 54.76% to $17.3 million in 2023, then decreased by 14.23% to $14.8 million in 2024, then grew by 10.78% to $16.4 million in 2025.
  • Its Inventory was $16.4 million in Q3 2025, compared to $12.1 million in Q2 2025 and $13.5 million in Q1 2025.